出典:Wikipedia
出典:『Wikipedia』 (2011/07/01 06:09 UTC 版)
Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.